Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van Campenhout A, Andersen GL, Aydin R, Becher JG, Bernert G, Caballero IM, Carr L, Valayer EC, Desiato MT, Fairhurst C, Filipetti P, Hassink RI, Hustedt U, Jozwiak M, Kocer SI, Kolanowski E, Krägeloh-Mann I, Kutlay S, Mäenpää H, Mall V, McArthur P, Morel E, Papavassiliou A, Pascual-Pascual I, Pedersen SA, Plasschaert FS, van der Ploeg I, Remy-Neris O, Renders A, Di Rosa G, Steinlin M, Tedroff K, Valls JV, Viehweger E, Molenaers G.

Eur J Paediatr Neurol. 2010 Jan;14(1):45-66. doi: 10.1016/j.ejpn.2009.09.005. Epub 2009 Nov 14. Review.

PMID:
19914110
[PubMed - indexed for MEDLINE]
2.

European consensus table 2006 on botulinum toxin for children with cerebral palsy.

Heinen F, Molenaers G, Fairhurst C, Carr LJ, Desloovere K, Chaleat Valayer E, Morel E, Papavassiliou AS, Tedroff K, Ignacio Pascual-Pascual S, Bernert G, Berweck S, Di Rosa G, Kolanowski E, Krägeloh-Mann I.

Eur J Paediatr Neurol. 2006 Sep-Nov;10(5-6):215-25. Epub 2006 Nov 13. Review.

PMID:
17097905
[PubMed - indexed for MEDLINE]
3.

Treatment of cerebral palsy with botulinum toxin: evaluation with gross motor function measure.

Yang TF, Chan RC, Chuang TY, Liu TJ, Chiu JW.

J Formos Med Assoc. 1999 Dec;98(12):832-6.

PMID:
10634023
[PubMed - indexed for MEDLINE]
4.

The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy.

Criswell SR, Crowner BE, Racette BA.

Neurosurg Focus. 2006 Aug 15;21(2):e1. Review.

PMID:
16918222
[PubMed - indexed for MEDLINE]
5.

Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment.

Russman BS, Tilton A, Gormley ME Jr.

Muscle Nerve Suppl. 1997;6:S181-93. Review.

PMID:
9826990
[PubMed - indexed for MEDLINE]
6.

Medical and surgical procedures experienced by young children with cerebral palsy.

McLellan A, Cipparone C, Giancola D, Armstrong D, Bartlett D.

Pediatr Phys Ther. 2012 Fall;24(3):268-77. doi: 10.1097/PEP.0b013e31825be2f6.

PMID:
22735479
[PubMed - indexed for MEDLINE]
7.

The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy.

Pidcock FS.

J Pediatr. 2004 Aug;145(2 Suppl):S33-5. Review.

PMID:
15292885
[PubMed - indexed for MEDLINE]
8.

The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial.

Boyd RN, Dobson F, Parrott J, Love S, Oates J, Larson A, Burchall G, Chondros P, Carlin J, Nattrass G, Graham HK.

Eur J Neurol. 2001 Nov;8 Suppl 5:109-19.

PMID:
11851739
[PubMed - indexed for MEDLINE]
9.

The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years.

Beckung E, Carlsson G, Carlsdotter S, Uvebrant P.

Dev Med Child Neurol. 2007 Oct;49(10):751-6.

PMID:
17880644
[PubMed - indexed for MEDLINE]
10.

Children undergoing treatment with botulinum toxin: the role of the physical therapist.

Leach J.

Muscle Nerve Suppl. 1997;6:S194-207. Review.

PMID:
9826991
[PubMed - indexed for MEDLINE]
11.

The use of botulinum toxin in pediatric disorders.

Gaebler-Spira D, Revivo G.

Phys Med Rehabil Clin N Am. 2003 Nov;14(4):703-25. Review.

PMID:
14580033
[PubMed - indexed for MEDLINE]
12.

Validation of a model of gross motor function for children with cerebral palsy.

Palisano RJ, Hanna SE, Rosenbaum PL, Russell DJ, Walter SD, Wood EP, Raina PS, Galuppi BE.

Phys Ther. 2000 Oct;80(10):974-85.

PMID:
11002433
[PubMed - indexed for MEDLINE]
Free Article
13.

[Botulinum toxin in the treatment of cerebral palsy].

Hayek S, Fatal-Valevski A.

Harefuah. 2000 Jan 16;138(2):144-7. Review. Hebrew. No abstract available.

PMID:
10883079
[PubMed - indexed for MEDLINE]
14.

Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.

Linder M, Schindler G, Michaelis U, Stein S, Kirschner J, Mall V, Berweck S, Korinthenberg R, Heinen F.

Eur J Neurol. 2001 Nov;8 Suppl 5:120-6.

PMID:
11851740
[PubMed - indexed for MEDLINE]
15.

Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation?

Forssberg H, Tedroff KB.

Dev Med Child Neurol. 1997 Sep;39(9):635-40. No abstract available.

PMID:
9344058
[PubMed - indexed for MEDLINE]
16.

[Treatment with botulinum toxin in neurologic pediatrics].

Justus N, Lee SH, Berweck S, Heinen F.

Kinderkrankenschwester. 2007 Jul;26(7):274-6. Review. German. No abstract available.

PMID:
17726921
[PubMed - indexed for MEDLINE]
17.

Changes over years in gross motor function of 3-8 year old children with cerebral palsy: using the Gross Motor Function Measure (GMFM-88).

Harries N, Kassirer M, Amichai T, Lahat E.

Isr Med Assoc J. 2004 Jul;6(7):408-11.

PMID:
15274531
[PubMed - indexed for MEDLINE]
Free Article
18.

The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial.

Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG, Jongerius PH, Becher JG.

Arch Phys Med Rehabil. 2006 Dec;87(12):1551-8.

PMID:
17141633
[PubMed - indexed for MEDLINE]
19.

When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy.

Heinen F, Schroeder AS, Fietzek U, Berweck S.

Mov Disord. 2006 Nov;21(11):2029-30. No abstract available.

PMID:
16972275
[PubMed - indexed for MEDLINE]
20.

Outcome measures used in studies of botulinum toxin in childhood cerebral palsy: a systematic review.

Baird MW, Vargus-Adams J.

J Child Neurol. 2010 Jun;25(6):721-7. doi: 10.1177/0883073809346846. Epub 2009 Oct 6. Review.

PMID:
19808988
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk